| |
|
| |
 |
 |
 |
| |
|
| |
The Company is investing heavily
in R&D to provide scientists with innovative solutions that allow
the development of models with high predictability in a shorter period
of time. A large proportion of these investments is dedicated to
validating and standardizing technologies. Reliability is one of
our most important commitment. To leverage these investments, genOway
is strongly committed to joint research with both academic institutes
and companies. genOway’s collaborative policy and expectations are
described under Partnerships.
|
| |
|
| |
 |
By using “models” such as
animals or cells, researchers try to predict the answers they
would obtain directly if they could perform the experiments
in humans. To increase the quality of the results obtained
from their research, scientists require innovative models
that provide results closer to human physiology. genOway develops
solutions to increase
the predictability of the research performed. |
|
| |
|
| |
 |
Scientific and economic competition
is so acute that scientists need shorter
and surer model development time. To achieve these
goals genOway has developed and is still investing in proprietary
technologies. |
|
| |
|
| |
To combine the two advantages,
genOway is developing proprietary Products
that will be available to the scientific community .
|
| |
|